Transcriptomics-guided high-throughput drug screening identifies potent therapies for P53 pathway altered DIPG/DMG. Jiang Z, Xie L, Zhou H, Geng Y, et al. Neuro Oncol 2026;28:251-267.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jiang Z, Xie L, Zhou H, Geng Y, et al. Transcriptomics-guided high-throughput drug screening identifies potent therapies for P53 pathway altered DIPG/DMG. Neuro Oncol 2026;28:251-267.
PMID: 40973093